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Abstract
Objectives. We aimed to evaluate the use of an eHealth platform and a self-management outpatient
clinic in patients with RA in a real-world setting. The effects on health-care utilization and disease
activity were studied.
Methods. Using hospital data of patients with RA between 2014 and 2019, the use of an eHealth
platform and participation in a self-management outpatient clinic were studied. An interrupted time
series analysis compared the period before and after the introduction of the eHealth platform.
The change in trend (relative to the pre-interruption trend) for the number of outpatient clinic visits and
the DAS for 28 joints (DAS28) were determined for several scenarios.
Results. After implementation of the platform in April 2017, the percentage of patients using it was stable at
37%. On average, the users of the platform were younger, more highly educated and had better health out-
comes than the total RA population. After implementation of the platform, the mean number of quarterly outpa-
tient clinic visits per patient decreased by 0.027 per quarter (95% CI: 0.045, 0.08, P¼ 0.007). This was ac-
companied by a significant decrease in DAS28 of 0.056 per quarter (95% CI: 0.086, 0025, P¼ 0.001). On
average, this resulted in 0.955 fewer visits per patient per year and a reduction of 0.503 in the DAS28.
Conclusion. The implementation of remote patient monitoring has a positive effect on health-care utiliza-
tion, while maintaining low disease activity. This should encourage the use of this type of telemedicine in the
management of RA, especially while many routine outpatient clinic visits are cancelled owing to COVID-19.
Key words: rheumatology, self-management, telemedicine, remote monitoring, eHealth, disease activity,
health-care utilization
Introduction
The World Health Organization estimates that by 2030
there will be a shortage of 18 million health workers,
owing to further increase in health-care utilization [1].
In Western countries, the increasing prevalence of
chronic diseases is a growing burden to an already
overextended health-care system [2]. For rheumatic
services, the demand is exceeding supply, as reflected
Key messages
. Real-world implementation of remote monitoring can reduce the number of hospital visits, while maintaining
disease control.
. Mainly younger and more highly educated patients, with lower disease activity, participate in telemedicine.
. The combination of self-management and telemedicine has the potential to replace labour-intensive outpatient
clinic visits.
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by long waiting lists in many countries [3]. The expecta-
tion is that this demand will continue to increase over
the coming years [4]. Simultaneously, the workforce is
declining because of an ageing population, while devel-
opments in labour productivity in health care are lagging
[5, 6]. Therefore, structural changes are needed to de-
liver an increasing amount of care with the same capac-
ity of people and resources [7]. According to the Dutch
Health Authority, a more rapid introduction of digitaliza-
tion in health care is needed [8]. Digitalization can help
to optimize health care by improving the lagging produc-
tivity [6] Both the potential and importance of digitaliza-
tion have become even clearer in recent months,
because it was impossible to deliver care as usual ow-
ing to the arrival of the severe acute respiratory syn-
drome coronavirus 2 (SARS-CoV-2) [9].
For instance, telemedicine (i.e. delivery of health-
care services through the use of information and com-
munication technologies in a situation where the actors
are in different locations: remote monitoring [10]) can
be used to replace, in part, outpatient visits and other
labour-intensive care [7, 8]. The management of RA
lends itself for the use of remote monitoring. RA is a
chronic disease that often requires lifelong hospital vis-
its. Owing to the routine character (every 3–6 months)
of these hospital visits and the variable disease course
of RA, patients are often doing well at the time of con-
sultation, and little action is needed [11]. At the same
time, routine outpatient visits are unable to support
patients if they experience a flare of their disease in
between visits [12]. By supporting self-management
and providing education about the disease in general,
patients will gain more insight into the individual course
of their disease. This will help patients to manage their
disease better, which, in turn, will improve their health
outcome [13].
The first studies evaluating remote monitoring for the
treatment of rheumatic diseases are promising, with high
patient satisfaction and equal or higher effectiveness
compared with the face-to-face approach [14, 15]. The
use of patient-reported outcome measures (PROMs) to
assess disease activity and patient-initiated visits makes
it possible to achieve similar disease control with fewer
outpatient clinic visits [16, 17]. However, research set-
tings the patients participating in these remote monitor-
ing programmes are often a selective group. This group
consists of patients who are younger or less sick [15], of-
ten with a higher level of education [18]. This selection
reflects that there is still a large group who feels reluctant
to participate in remote monitoring programmes and tele-
medicine [19].
However, telemedicine is not merely a change in organi-
zation and coordination of care; it is a different way of
thinking about care as a system, and the position of
patients in it [20]. A prerequisite for telemedicine to be suc-
cessful is that the patient becomes a partner in care [7].
Therefore, to support patients in their self-management
behaviour and improve patient engagement, the eHealth
platform Reumanet Bernhoven was introduced in April
2017 [21]. Reumanet Bernhoven is an eHealth platform
that helps patients and health professionals to manage
rheumatic disease. The aim of this platform is to increase
the number of patients who feel adequately equipped to
perform self-management and to improve patient engage-
ment at a population level.
At the same time, research shows that successful dis-
ease monitoring by the patient helps to replace lifelong
physician-initiated visits with patient-initiated visits [15].
This will reduce the number of routine visits of patients
with stable disease, creating more time to review patients
with an active disease in a timely manner. In order to
teach patients the competencies required for successful
self-management, the self-management outpatient clinic
(SMOC) was started in March 2018 in Bernhoven. In the
SMOC, patients are coached by a trained nurse specialist
to use their own abilities to self-monitor their disease (fa-
cilitated through the eHealth platform). This aims to reduce
the number of unnecessary hospital visits, while maintain-
ing disease control.
This study has three aims: to evaluate the use of an
eHealth platform and the different levels of participa-
tion; to study the influence of introducing an eHealth
platform promoting self-management on disease
activity and the number of hospital visits in the RA pop-
ulation; and to study the impact of remote monitoring




This observational study evaluates the use of an eHealth
platform and different levels of participation in the
Department of Rheumatology at Bernhoven using a real-
world design setting. It studies the effects of implement-
ing an eHealth platform with regard to disease activity
and health-care utilization using an interrupted time se-
ries design between July 2014 and October 2019. The
study also analyses the patients participating in the
SMOC and their disease activity and health-care utiliza-
tion. Data on all patients with a clinical diagnosis of RA
according to the 2010 ACR criteria were collected from
the Reumanet Bernhoven registry and included in the
analysis [22]. All patients had provided written informed
consent for the use of their data for scientific purposes
at an earlier time point. All procedures were performed
in accordance with the ethical standards of the institu-
tional and national research committee and with the
1964 Declaration of Helsinki and its later amendments
or comparable ethical standards. According to the medi-
cal ethical review committee of the region Arnhem-
Nijmegen, this study does not require ethical approval,
because only data used for daily clinical practice were
collected (file number 2020-6729).
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Reumanet Bernhoven
In April 2017, the eHealth platform Reumanet Bernhoven
(Philips VitalHealth software, Ede, Netherlands) was
launched [21]. The platform includes data on all patients
diagnosed with RA under treatment at the
Rheumatology Department in Bernhoven and is auto-
matically available for the patient and the rheumatolo-
gist. With permission of the patient, other health
professionals can also gain access (e.g. the nurse, gen-
eral practitioner or physiotherapist). The platform pro-
vides the patient with disease-specific information in the
form of a library, contains eHealth modules and provides
insight into personal medical data, such as medication
history and laboratory values. Patients can also monitor
their disease activity by using PROMs. Reumanet
Bernhoven also includes graphical overviews of disease
activity and PROMs, lifestyle advice, and a chat function
is available to send messages between the patient and
health professional. To improve uptake of Reumanet
Bernhoven, special attention was given to making the
process as inclusive as possible. For example, educa-
tional classes on how to log in and use Reumanet
Bernhoven were offered to support those who lacked
skills, and reminders to fill out questionnaires were sent
to patients at patient-specific time points.
Self-management outpatient clinic
The SMOC was initiated in March 2018. The aim of this
outpatient clinic was to provide patients who were in re-
mission or have low disease activity with the opportunity
to self-manage their disease and thereby reduce the
number of consultations at the Department of
Rheumatology. Patients with a clinical diagnosis of RA,
either in stable remission or with low disease activity,
who were motivated to take part in the self-
management programme and able to use Reumanet
Bernhoven were invited to participate in the SMOC.
After giving informed consent, the patient received infor-
mation from a trained nurse specialist about the aim of
the SMOC, how to use Reumanet Bernhoven, what to
expect from the health professionals and how to contact
the outpatient clinic in case they had questions. Patients
participating in the SMOC were required to have one
consultation with the rheumatologist per year and were
asked to fill in the rheumatoid arthritis impact of disease
(RAID) [23] to track their disease activity. Patients were
obliged to undergo laboratory monitoring according to
the guidelines of the drugs they were using. The sam-
ples could be taken at a location of the patient’s choice
and were analysed at the laboratory of Bernhoven. The
results of these tests were reviewed by the health-care
professionals before sending a prescription for medica-
tion for the consecutive period. Patients were able to
contact a nurse specialist if they felt the need to, for ex-
ample, because of a self-monitored flare or an adverse
event, and could obtain a consultation within a few days
if the patient or nurse practitioner deemed this
desirable.
Measures
Baseline characteristics were age, biological sex, educa-
tional status, work status, smoking status, alcohol use,
disease duration, RF status, anti-CCP status, BMI and
medication use. As a measure of health-care utilization,
the number of RA-related outpatient clinic visits was
used. The DAS28 was used by the rheumatologist as a
measure for disease activity (score between 0 and 10,
with a higher score indicating higher disease activity)
[24]. The following PROMs were filled out: for functional
capacity, the HAQ [25] was used (score between 0 and
3, with a higher score indicating worse function and
greater disability); the 36-item short form health survey
(SF-36) [26] was used to measure health-related quality
of life (score between 0 and 100, with a higher score
indicating a better health-related quality of life); and to
assess the impact of RA from a patient perspective, the
RAID was scored (score between 0 and 10, with a
higher scores indicating worse impact of disease).
The following measurements and questionnaires could
be entered by the patient: educational status, working
status, smoking status, alcohol use, HAQ, SF36, RAID
and visual analog scales for pain and tiredness.
Evaluation of self-management through use of the
eHealth platform
To evaluate the utilization of the eHealth platform, we
categorized the RA population based on the level of uti-
lization. First, we divided the population into two groups:
patients who had an email address and therefore had
the possibility of logging into Reumanet Bernhoven (po-
tential users) and those without the possibility of logging
in (non-users). Second, we identified the subgroup of
patients who had logged in (active users). Given that
Reumanet Bernhoven offers the possibility of filling out
yearly questionnaires, a 1-year cut-off was used to iden-
tify active users. Third, we identified those patients who
regularly performed PROMs as part of follow-up within
the SMOC.
Interrupted time series analyses
To study the effect of the introduction of Reumanet
Bernhoven on health-care utilization and disease activ-
ity, a single-centre interrupted time series analysis was
performed on the total population and on the subgroup
of patients who eventually participated in the SMOC.
The interruption in the time series (quarterly intervals)
was placed in April 2017 (i.e. the introduction of the
platform). The interrupted time series design attempted
to assess whether the Reumanet Bernhoven intervention
had a significant effect on health-care utilization and
DAS28 compared with the underlying trend. The pre-
intervention trend served as the control [27].
Autocorrelation in the error distribution was tested by
the Cumby–Huizinga general test for autocorrelation.
Depending on the outcome of this test, one or more
lags were added to the model. Statistical analyses were
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done in STATA v.15.1 (TX: StataCorp LLC, College
Station).
Results
Participation in Reumanet Bernhoven and the self-
management outpatient clinic
Since the initiation of the eHealth platform and the
SMOC, the utilization of these programmes has in-
creased gradually over time (Fig. 1). However, most of
the uptake of Reumanet Bernhoven occurred in the
quarter immediately after its introduction, and it was dif-
ficult to increase this number over time. By November
2019, 1145 patients with RA were treated at the
Rheumatology Department of Bernhoven and therefore
included in Reumanet Bernhoven. By then, 818 (71% of
the RA population) had uploaded their email address
and were able to log into Reumanet Bernhoven. Of
those, 434 patients (38% of the RA population) had
done so in the last year and were considered as active
users of Reumanet Bernhoven. Of this group, 110
patients (10% of the RA population) were included in
the SMOC (a flow diagram is provided as
Supplementary Fig. S1, available at Rheumatology
Advances in Practice online).
Patient characteristics of groups based on the
usage of Reumanet Bernhoven
Table 1 shows the patient characteristics on 1 January
2019 of the total RA population (split into potential users
and active users) and of the patients who participated in
the SMOC between November 2017 and November
2019. It is noteworthy that the patients who used
Reumanet Bernhoven and participated in the SMOC
tended to be younger, more highly educated and have
better health outcomes. Moreover, we observed that
they seemed to use more medication, consume more al-
cohol and be more likely to have stopped smoking.
Interrupted time series analyses of the introduction
of Reumanet Bernhoven
The mean number of outpatient clinic visits in the total
RA population in July 2014 was estimated at 0.94 visits
per patient per quarter (Fig. 2). Before the introduction
of the eHealth platforms, there was a non-significant de-
creasing trend in the number of quarterly visits of
0.002 per quarter (95% CI: 0.123, 0.009, P¼ 0.766).
After the introduction of the eHealth platform, the mean
number of quarterly outpatient clinic visits decreased
significantly each quarter by 0.027 (relative to the pre-
interruption trend; 95% CI: 0.045, 0.08, P¼ 0.007).
The decline in quarterly visits was even more prominent
in the subgroup who eventually participated in the
SMOC (Fig. 3). In July 2014, they had a comparable
mean number of outpatient clinic visits of 0.91 per pa-
tient per quarter. Before the introduction of the eHealth
platform, their mean number of outpatient clinics visits
decreased non-significantly by 0.003 per quarter (95%
CI: 0.009, 0.003, P¼ 0.297). After the introduction of
the eHealth platform, the trend for the number of quar-
terly visits decreased significantly by 0.059 per quarter
(relative to the pre-interruption trend; 95% CI: 0.078,
0.040, P<0.001).
The mean DAS28 of the total RA population in July
2014 was estimated to be 3.19 (Fig. 4). Before the intro-
duction of the eHealth platform, there was an non-
significant increase in the DAS28 of 0.014 per quarter
(95% CI: 0.006, 0.034, P¼ 0.164). After the introduc-
tion of the eHealth platform, the mean DAS28 decreased
significantly (relative to the pre-interruption trend) by
0.056 per quarter (95% CI: 0.086, 0025, P¼0.001).
The mean DAS28 of the subgroup of patients who
would end up participating in the SMOC was estimated
FIG. 1 Utilization of Reumanet Bernhoven between August 2017 and November 2019
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TABLE 1 Patient characteristics on 1 January 2019 for the total RA population
Patient characteristics Total population Potential users Active users Self-management clinic
n¼1059 n¼761 n¼360 n¼110
Age, years, mean (S.D.) 64 (13) 1059 61 (13) 761 59 (11) 360 57 (11) 110
Female, % 67 705/1059 65 497/761 65 235/360 66 72/110
BMI, kg/m2, mean (S.D.) 27 (5.1) 502 27 (5.1) 370 27 (5.3) 174 26 (4.8) 65
Anti-CCP positive, % 56 418/761 53 300/566 56 138/248 64 59/92
RF positive, % 61 443/723 59 308/526 63 147/233 61 54/88
Smoking status
Current smoker, % 19 61/322 18 33/186 13 20/151 5 3/55
Stopped smoking, % 46 149/322 51 95/186 54 82/151 62 34/55
Never smoked, % 35 112/322 31 58/186 33 49/151 33 18/55
Consumes alcohol, % 62 198/322 70 131/186 70 105/151 76 42/55
Highest education
High, % 12 38/318 15 28/186 18 27/151 31 17/55
Middle, % 25 79/318 31 58/186 30 45/151 27 15/55
Low, % 63 201/318 54 100/186 52 79/151 42 23/55
Health outcome
DAS28, median (IQR) 2.6 (2.0–3.4) 863 2.6 (2.0–3.2) 642 2.5 (1.9–3.1) 339 2.1 (1.7–2.7) 109
HAQ, median (IQR) 0.50 (0.12–1.3) 272 0.38 (0–1.0) 182 0.38 (0–0.94) 169 0.32 (0–0.75) 78
SF36 PCS, median (IQR) 43 (35–51) 166 44 (37–52) 133 44 (37–52) 129 48 (40–53) 63
SF36 MCS, median (IQR) 50 (42–58) 166 50 (42–56) 133 51 (42–56) 129 54 (47–60) 63
Medication use
Biologic users, % 20 214 22 171 24 87 30 33
csDMARD users, % 75 797 75 569 77 277 85 94
No DMARD therapy, % 18 196 19 145 17 61 6 7
Patient characteristics are split into the potential users, the active users, and the patients who participated in the self-
management outpatient clinic between November 2017 and November 2019. csDMARD: conventional synthetic DMARD;
DAS28: disease activity score for 28 joints; IQR: interquartile range; SF: short form; PCS: physical component score; MCS:
mental component score.
FIG. 2 Outpatient clinic visits in the total RA population
The mean number of outpatient clinic visits per patient per quarter in the total RA population between July 2014 and
October 2019.
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to be 2.94 in July 2014 (Fig. 5). Their mean DAS28
decreased significantly by 0.023 per quarter (95% CI:
0.041, 0.005, P¼ 0.015) before the introduction of
the eHealth platform. After the introduction of the
eHealth platform, the quarterly post-interruption trend
of the DAS28 (relative to the pre-interruption trend)
stayed approximately the same (CI: 0.036, 0.047,
P¼0.962).
FIG. 3 Outpatient clinic visits of the patients who would end up participating in the self-management outpatient clinic
The mean number of outpatient clinic visits per patient per quarter of the patients who would end up participating in
the self-management outpatient clinic between July 2014 and October 2019.
FIG. 4 DAS28 of the total RA population
The mean DAS for 28 joints (DAS28) of the total RA population between July 2014 and October 2019.
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Discussion
After the implementation of Reumanet Bernhoven, there
was a significant decrease in the number of outpatient
clinic visits over time, without compromising disease
control. Participation in the SMOC reduced the health-
care utilization even more, without affecting the pre-
existing decreasing trend in DAS28 present in this
group. During this period, both the percentage of poten-
tial Reumanet Bernhoven users and the percentage of
patients participating in the SMOC increased, whereas
the percentage of patients regularly using Reumanet
Bernhoven did not increase after the initial uptake. On
average, the users of Reumanet Bernhoven were youn-
ger, more highly educated and had better health out-
comes. This difference was even more evident in those
who participated in the SMOC.
Our real-world data match positive results from clini-
cal trials investigating self-management supported by
eHealth applications and patient-initiated visits for the
treatment of rheumatic diseases [14–18]. We found a
decrease in health-care utilization after the implementa-
tion of telemedicine. This was accompanied by a clini-
cally non-significant improvement in health outcome,
showing at least non-inferiority compared with care as
usual. This adds to the growing body of evidence con-
cluding that telemedicine methods can be implemented
safely in RA. These findings are also relevant in the
treatment of other rheumatic diseases and even other
chronic diseases. Owing to SARS-CoV-2, many routine
outpatient clinic visits have been cancelled, and the ex-
pectation is that it might take years before things get
back to normal. Therefore, eHealth applications can be
used to support patients in their increased need for self-
management, whereas patient-initiated visits can help to
select those patients who need to be seen at the outpa-
tient clinic.
The inclusiveness of telemedicine remains an impor-
tant issue. The goal of Reumanet Bernhoven was to im-
prove patient engagement and to increase the number
of patients who feel adequately equipped to perform
self-management. To achieve this, particular attention
was given to making the process as inclusive as possi-
ble during the implementation of Reumanet Bernhoven.
These efforts led to an increase in the percentage of
patients who were able to log into the eHealth platform
(from 55 to 71% of the population). However, most of
the active users engaged early on, and the percentage
who used the eHealth platform remained stable at
37%. This illustrates that more efforts are needed in
order to motivate more patients to participate in this
self-management programme. This low percentage cor-
responds to other real-world data, where only 34% of
the patients engaged in self-management [13]. At the
same time, our data show that it is a select group that
participates in telemedicine, i.e. the younger, more
highly educated patients with low disease activity. This
matches findings from systematic reviews assessing the
participants of patient-initiated follow-up and eHealth
programmes for the treatment of chronic diseases [15,
FIG. 5 DAS28 of the patients who would end up participating in the self-management outpatient clinic
The mean DAS for 28 joints (DAS28) of the patients who would end up participating in the self-management
outpatient clinic between July 2014 and October 2019.
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28]. This selective use of telemedicine, whereby eHealth
is least used by the people who need it most, risks wid-
ening the gap between those at risk of social health
inequalities and the rest of the population [28, 29]. The
effects of selective use of telemedicine on inequality and
access to care should therefore be monitored.
Different factors influence whether a patient will partici-
pate in self-management. For instance, patients with
chronic rheumatic diseases perceive different levels of
self-management as suitable for themselves and there-
fore do not always see themselves as partners in care
[30]. Lack of information and lack of self-monitoring skills
are perceived as barriers to perform self-management
[30]. The high number of people with low health literacy
and low health skills (29% of the Dutch population) fur-
ther complicates self-management [31–33]. Therefore,
further implementation of telemedicine requires good
guidance, offering a tailor-made approach and focusing
on those at risk of social health inequalities [29].
Concurrently, we think that it is important to acknowledge
that, at least at the moment, not all patients are capable
of performing self-management and telemedicine.
Adequate selection of which level of self-management
can be expected of an individual patient is essential. In
our opinion, this task is best performed by a nurse spe-
cialist affiliated with the SMOC. They often have more
time and skills to explore patients’ conditions and needs.
In addition, patients often experience a special relation-
ship of trust with their nurse specialist that allows for a
tailor-made approach aimed at tackling the aforemen-
tioned barriers [25]. Using this relationship of the nurse
with the patient can help to increase the participation in
self-management and telemedicine.
Interestingly, we have noticed in recent months an in-
crease in patients who have actively enquired regarding
the possibilities of performing telemedicine. This in-
crease has coincided with the SARS-CoV-2 pandemic in
The Netherlands. Owing to SARS-CoV-2, there has been
an increase in Internet use by the elderly, the group cur-
rently under-represented in Reumanet Bernhoven users
[34]. Simultaneously, the outpatient clinic had to close
down somewhat, reducing the possibility for outpatient
clinic visits. The fact that Reumanet Bernhoven was still
readily available might have helped people to overcome
the barriers normally perceived. This change in patients
participating in telemedicine should be monitored
closely, because changes in the composition of the par-
ticipating population could influence the effectiveness of
telemedicine. Before telemedicine can be applied for the
whole population, we should know the effectiveness of
telemedicine in the groups currently unlikely to
participate.
This study evaluated the use of Reumanet Bernhoven
and participation in the SMOC in a real-world setting. A
strength of this study is that it offered the opportunity to
assess which patients chose to use these programmes
in daily clinical practice. Participants in the programme
were clearly a self-selected group, which is currently the
daily reality [15, 28]. As previously mentioned, efforts will
have to focus on increasing the number of participants
of the programme. A limitation of observational data is
the difficulty in assessing the causality of interventions.
Given that the study period was lengthy, external fac-
tors, such as advances in treatment options or changes
in treatment guidelines, could potentially influence dis-
ease activity and, to a lesser extent, the number of hos-
pital visits. An interrupted time series design is capable
of identifying these underlying trends and isolates the ef-
fect of the introduction of Reumanet Bernhoven [35]. By
using the pre-interruption trend as a control, the ob-
served differences are more likely to be attributable to
the studied interventions. This strengthens the confi-
dence that the observed effect can be attributed to the
introduction of Reumanet Bernhoven, especially be-
cause, as far as we know, during that time period no
changes in other factors that could explain the underly-
ing trend for health-care utilization occurred.
In conclusion, the implementation of Reumanet
Bernhoven, an eHealth platform aimed at supporting
patients in their self-management need, resulted in less
health-care utilization, while maintaining disease control.
Making use of patient-initiated visits in patients with sta-
ble disease activity resulted in an even larger reduction
of health-care utilization. Policy-makers should use the
momentum telemedicine has gained recently owing to
the SARS-CoV-2 pandemic to embed telemedicine
firmly into the health-care system, in particular, with the
expected cutbacks in mind, required owing to the pan-
demic. Concomitantly, health-care professionals need to
remain vigilant to ensure that those currently unable to
participate in telemedicine receive the care they need.
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